|
CDC7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.000400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89859999999831E-05 |
| Normal-vs-Stage2 |
4.129800E-01 |
| Normal-vs-Stage3 |
4.882000E-03 |
| Normal-vs-Stage4 |
1.207590E-01 |
| Stage1-vs-Stage2 |
3.178100E-03 |
| Stage1-vs-Stage3 |
2.154600E-01 |
| Stage1-vs-Stage4 |
4.210100E-02 |
| Stage2-vs-Stage3 |
5.723900E-02 |
| Stage2-vs-Stage4 |
4.348400E-01 |
| Stage3-vs-Stage4 |
3.140000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.261790E-03 |
| Normal-vs-AfricanAmerican |
4.676500E-02 |
| Normal-vs-Asian |
1.25659999961059E-07 |
| Caucasian-vs-AfricanAmerican |
9.655000E-01 |
| Caucasian-vs-Asian |
8.02300000000145E-05 |
| AfricanAmerican-vs-Asian |
1.344310E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.196900E-03 |
| Normal-vs-Female |
4.409300E-04 |
| Male-vs-Female |
7.026000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.16019999999384E-05 |
| Normal-vs-Age(41-60Yrs) |
5.841800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.359800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.356100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.881500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.638400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.721000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.314800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.844200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.901200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.029400E-01 |
| Classical-VS-Follicular |
5.630200E-04 |
| Classical-VS-Other |
3.257400E-01 |
| Classical-VS-Normal |
3.72539999999866E-05 |
| Tall-VS-Follicular |
1.132380E-01 |
| Tall-VS-Other |
4.935200E-01 |
| Tall-VS-Normal |
1.010470E-02 |
| Follicular-VS-Other |
8.632600E-01 |
| Follicular-VS-Normal |
2.369800E-01 |
| Other-VS-Normal |
4.481200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.061900E-03 |
| Normal-vs-N1 |
3.356700E-03 |
| N0-vs-N1 |
3.546000E-01 |
|
|
